Ellen Friday, PhD, Clinical Assistant Professor and Researcher at LSUHS, is among the first 100 people globally to pass the QBRS exam and receive this credential, a distinction among biorepository science professionals.
J. Steven Alexander, PhD, Professor of Molecular and Cellular Physiology at LSU Health Shreveport, and his company, Arganum Transplant Solutions, was named the winner of Startup Prize 2021: Focus on Health. Arganum Transplant Solutions aims to transform the organ preservation market.
Shreveport Times - Research Notebook: Since the earliest days of the COVID-19 pandemic scientists around the world have been working together on critical genomic sequencing efforts to better understand how the SARS-CoV-2 virus spreads and evolves and help guide and evaluate public health response.
Bloomberg - While the U.S. is sequencing a much higher percentage of Covid samples than earlier, the bigger issue may be that not enough virus testing is done in the first place, said Jeremy Kamil, a virologist at Louisiana State University Health Shreveport.
A new variant of COVID-19 has been identified in Louisiana by scientists at the LSU Health Shreveport Emerging Viral Threats Center. LSUHS announced this month that the B.1.630 variant had been sequenced and reported by the center, though health officials believe this variant's predominance is very low and much less transmissable than the deadly delta variant.
The EVT Viral Genomics and Sequencing Lab at LSU Health Shreveport is first in the state to sequence and report that a new variant of SARS-CoV-2, the virus that causes COVID-19, has been detected in Louisiana. The new variant, B.1.630, was sequenced last week from two samples collected in Baton Rouge.
LSU Health Shreveport has been on the front line fighting the COVID-19 pandemic since the beginning. The establishment of the Emerging Viral Threats lab in March of 2020 led to mass testing and vaccination sites, clinical trials in patient treatment options and viral sequencing that discovered 7 COVID-19. variants.
Wall Street Journal - Some virologists believe the Delta variant evolved to maximize transmissibility and that its ability to spread rapidly will eventually reach a ceiling as more of the global population gets vaccinated. “It looks like this virus is already driving a Lamborghini right now in terms of transmissibility, so I’m not sure it can get much faster,” said Jeremy Kamil, a virologist at LSU Health Shreveport who is studying coronavirus genetics. Read the full article.
The research of Lynn Harrison, PhD, Professor of Molecular and Cellular Physiology at LSUHS, was selected by NASA’s Space Biology Program as one of three space biology proposals to prepare for future research on the surface of the moon.
Mabruka Alfaidi, PhD, Postdoctoral Fellow in Pathology at LSU Health Shreveport, has been selected as a recipient of an American Heart Association Career Development Award. This prestigious award supports highly promising healthcare and academic professionals in the early years of their career by funding innovative research and training to assure the future success of the awardee as a cardiovascular independent scientist.
Wayne Nix has been named the new Chief Innovation Officer of Research at LSUHS, effective July 15, 2021. Mr. Nix is an experienced entrepreneur with over 20 years of experience in both healthcare and business development and management arenas. He has also led many team innovation strategies while providing mentorship for new entrepreneurs.
BIZ Magazine - Celeste Y.C. Wu, PhD, post-doctoral fellow in the Department of Neurology at LSU Health Shreveport, was awarded the American Heart Association Career Development Award receiving $231,000 in funding.
PRNewswire — JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced the appointment of Nicholas E. Goeders, Ph.D. to its Scientific Advisory Board (SAB). Dr. Goeders is considered one of the world’s leaders on the role of stress in drug addiction.
Louisiana Radio Network - The objective of the grant is to strengthen global capabilities to detect and respond to pandemic threats in the future. Director for Emerging Viral Threats at LSUHS Dr. Andrew Yurochko said the award is indicative of LSU Health Shreveport’s strides in detecting variants and assisting with vaccine rollout.
Red River Radio - Work by Drs. Jeremy Kamil and Rona Scott along with COBRE principal investigators Drs. Andrew Yurochko and Chris Kevil has produced and shared 2,839 full coverage SARS-CoV-2 genomes, which amounts to over 60% of the SARSCoV-2 genome surveillance from Louisiana, and 1.2 % of the total US data submitted to GISAID which is the Global Initiative on Sharing All Influenza Data.